The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity.

Details

Ressource 1Download: 35706797_BIB_F421660A6587.pdf (712.71 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_F421660A6587
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity.
Journal
Translational cancer research
Author(s)
Elahi L., Zellweger M., Abdelnour-Berchtold E., Gonzalez M., Ris H.B., Krueger T., Raffoul W., Perentes J.Y.
ISSN
2219-6803 (Electronic)
ISSN-L
2218-676X
Publication state
Published
Issued date
05/2022
Peer-reviewed
Oui
Volume
11
Number
5
Pages
1162-1172
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Chest wall resections/reconstructions are a validated approach to manage tumors invading the thorax. However, how resection characteristics affect postoperative morbidity and mortality is unknown. We determined the impact of chest wall resection size and location on patient short and long-term postoperative outcomes.
We reviewed all consecutive patients who underwent resections/reconstructions for chest wall tumors between 2003 and 2018. The impact of chest wall resection size and location and reconstruction on perioperative morbidity/mortality and oncological outcome were evaluated for each patient.
Ninety-three chest wall resections were performed in 88 patients for primary (sarcoma, breast cancer, n=66, 71%) and metastatic (n=27, 29%) chest wall tumors. The mean chest bony resection size was 107 (range, 15-375) cm <sup>2</sup> and involved ribs only in 57% (n=53) or ribs combined to sternal/clavicular resections in 43% of patients (n=40). Chest defect reconstruction methods included muscle flaps alone (14%) prosthetic material alone (25%) or a combination of both (61%). Early systemic postoperative complications included pneumonia (n=15, 16%), atelectasis (n=6, 6%), pleural effusion (n=15, 16%) and arrhythmia (n=6, 6%). The most frequent long-term reconstructive complications included wound dehiscence (n=4), mesh infection (n=5) and seroma (n=4). Uni- and multivariable analyses indicated that chest wall resection size (>114 cm <sup>2</sup> ) and location (sternum) were significantly associated with the occurrence of pneumonia and atelectasis [odds ratio (OR) =3.67, P=0.05; OR =78.92, P=0.02, respectively]. Disease-free and overall survival were 37±43 and 48±42 months for primary malignancy and of 24±33 and 48±53 months for metastatic chest wall tumors respectively with a mean follow-up of 46±44 months.
Chest wall resections present good long-term oncological outcomes. A resection size above 114 cm <sup>2</sup> and the involvement of the sternum are significantly associated with higher rates of postoperative pneumonia/atelectasis. This subgroup of patients should have reinforced perioperative physical therapy protocols.
Keywords
Chest wall resectionchest wall reconstructionmorbidityoverall survival, Chest wall resection, chest wall reconstruction, morbidity, overall survival
Pubmed
Web of science
Open Access
Yes
Create date
31/03/2022 18:39
Last modification date
29/06/2023 6:38
Usage data